Double Blind, Safety and Immunogenicity Study of Recombinant Botulinum Vaccine A/B
Public ClinicalTrials.gov record NCT00764634. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2, Randomized, Double Blind, Placebo-Controlled, Multicenter Study to Evaluate Safety, Dosing Schedule and Antibody Kinetics of Recombinant Botulinum Vaccine A/B, rBV A/B-40, in Healthy Adults
Study identification
- NCT ID
- NCT00764634
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- DynPort Vaccine Company LLC, A GDIT Company
- Industry
- Enrollment
- 440 participants
Conditions and interventions
Conditions
Interventions
- Placebo (USP sterile saline for injection) Biological
- rBV A/B-40 vaccine Biological
Biological
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 31, 2008
- Primary completion
- Feb 28, 2010
- Completion
- Nov 30, 2010
- Last update posted
- Dec 1, 2011
2008 – 2010
United States locations
- U.S. sites
- 6
- U.S. states
- 5
- U.S. cities
- 6
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Miami Research Associates | Miami | Florida | 33143 | — |
| University Clinical Research, Inc | Pembroke Pines | Florida | 33024 | — |
| Johnson County Clin-Trials | Lenexa | Kansas | 66219 | — |
| Center for Pharmaceutical Research | Kansas City | Missouri | 64114 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Clinical Research Associates of Tidewater | Norfolk | Virginia | 23507 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00764634, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 1, 2011 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00764634 live on ClinicalTrials.gov.